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Objective. Neuronal precursor cell expressed developmentally down-regulated 4-like (NEDD4L) is a regulator of the amiloride-
sensitive epithelial sodium channel (ENaC), thus a candidate gene for salt sensitivity. Carriers of an intact NEDD4L C2-domain,
encoded by the NEDD4L rs4149601 (G/A) GG genotype, together with the C-allele of the NEDD4L rs2288774 (C/T)
polymorphism have previously been shown to have increased blood pressure. Our aim was to test if genetic variation in
NEDD4L is associated with increased salt sensitivity. Methods. 39 normotensive subjects were studied. The difference in 24-
hour systolic blood pressure after four weeks on 150 mmol/day NaCl intake and four weeks on 50 mmol/day NaCl was defined
as salt sensitivity. The rs4149601 and rs2288774 polymorphisms were genotyped using PCR-based techniques. Results.
Carriers of the rs4149601 GG-genotype together with the rs2288774 CC-genotype had significantly higher salt sensitivity
(median, IQR) (18.0, 7.5–20.0 mmHg vs 6.0, 0.0–10.0 mmHg, P=0.007) and lower plasma renin concentration (P-renin) (6.0, 2.0–
9.5 mU/L vs 15.0, 9.0–24.0 mU/L, P=0.005) as compared to non-carriers of these genotypes. In carriers of the rs4149601 GG-
genotype together with the rs2288774 CC- or CT-genotype, as compared to non-carriers, salt sensitivity was (8.0, 6.0–
18.0 mmHg vs 5.0, 0.0–10.0 mmHg, P=0.07) and P-renin (9.0, 6.0–16.0 mU/L vs 15.0, 9.0–28.0 mU/L, P=0.03). Conclusion.
Genetic NEDD4L variation seems to affect salt sensitivity and P-renin in normotensive subjects, suggesting that genotyping of
NEDD4L may be clinically useful in order to identify subjects who benefit from dietary salt restriction in the prevention of
hypertension.
Citation: Dahlberg J, Nilsson L-O, von Wowern F, Melander O (2007) Polymorphism in NEDD4L Is Associated with Increased Salt Sensitivity, Reduced
Levels of P-renin and Increased Levels of Nt-proANP. PLoS ONE 2(5): e432. doi:10.1371/journal.pone.0000432
INTRODUCTION
Hypertension is a major risk factor for cardiovascular morbidity
and mortality and affects 27% of the adult Swedish population [1].
Blood pressure has a normal distribution in the population
suggesting a multifactorial background of blood pressure regula-
tion and hypertension development. Genetic factors might explain
30–40% of population blood pressure variation [2] and the genetic
component is most likely composed of many individual genetic
variants. Environmental risk factors such as stressful lifestyle, lack
of physical exercise, high caloric intake and salt-rich diet also
contribute to elevated blood pressure and development of
hypertension. Furthermore, the environmental risk factors are
likely to interact with the genetic susceptibility variants. Given the
complex etiology and pathophysiology of hypertension, the search
for genetic variants of importance for blood pressure has been
suggested to be more comprehensible by dissecting an ‘‘in-
termediate phenotype’’ of blood pressure such as salt sensitivity.
Such a phenotype is plausibly influenced by substantially fewer
genes and environmental factors [3]. Salt sensitivity, i.e. the
individual blood pressure reaction to a given change in salt intake
is a continuous trait [4] and cut-off limits used to dichotomize the
trait are arbitrary and have differed between studies. The
heritability of systolic salt sensitivity calculated in Black pedigrees
has been shown to be as high as 74% suggesting a strong genetic
component of this trait [5]. In addition, hypertensive patients are
more salt sensitive than normotensive subjects [4] and normoten-
sive subjects with heredity for hypertension have increased salt
sensitivity [6], indicating that salt sensitivity is partially related to
an inherited predisposition for hypertension.
Salt restriction at the population level, with the aim to reduce
population blood pressure, is difficult to achieve [7,8] and its
ability to lower the incidence of cardiovascular disease is contro-
versial. However, identifying and intervening with salt restriction
in the most salt sensitive segment of the population would
probably be a very cost-effective way of treating and preventing
hypertension in this particular subset of the population. In a clinical
context it is cumbersome to measure salt sensitivity. It therefore
seems essential to identify bio-markers for salt sensitivity and thus
provide physicians a manageable tool of whom to give intense
educational dietary advice. We have previously shown that salt
sensitivity, defined as the difference between blood pressure after
one week of high (240 mmol daily) and one week of low (10 mmol
daily) salt intake is directly correlated to N-terminal atrial naturetic
peptide (Nt-proANP) and inversely correlated to plasma renin
activity [9,10]. In a study recently completed, ‘‘Salt Reduction to
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defined as the difference between blood pressure after four weeks
of high (150 mmol daily) and four weeks of low (50 mmol daily)
salt intake, i.e. a more clinically relevant intervention, was directly
correlated to Nt-proANP and inversely correlated to plasma
concentration of renin (P-renin) [11]. These studies thus suggest
that renin and Nt-proANP may be used to predict salt sensitivity.
It has been proposed that salt sensitivity is related to the inability
of the kidney to excrete sodium [12,13]. Most monogenic forms of
human hypertension are caused by mutations increasing renal
sodium reabsorption primarily at the level of the amiloride
sensitive sodium channel (ENaC) [14,15]. These rare forms of
hypertension are further characterized by extreme salt sensitivity
and suppressed P-renin. Although salt sensitivity and the accom-
panying P-renin suppression we have observed at the population
level is usually far from as extreme as that seen in monogenic
forms of hypertension, the clinical resemblance between them
suggests that salt sensitivity may have partially similar pathophys-
iology as monogenic forms of hypertension. In one of the mono-
genic forms of hypertension, Liddle’s syndrome, activating ENaC
mutations affect the PY motif of ENaC with the consequence that
ENaC becomes insensitive to down regulation by a protein coded
by the Neural precursor cell Expressed Developmentally Down-
regulated 4 Like (NEDD4L) gene [16,17]. Normally the NEDD4L
protein interacts with the PY motif and regulates the cell surface
expression of ENaC by ubiquination, thereby affecting the rate of
sodium reabsorption in the distal nephron.
We recently showed that a combination of two common single
nucleotide polymorphisms (SNP:s) (rs4149601 and rs2288774)
located in the NEDD4L gene is associated with blood pressure
variation in a population study from Malmo ¨, Sweden [18]. The
GRA substitution of the rs4149601 polymorphism at the first
nucleotide of exon 1 of the NEDD4L gene leads to an alternative
splice site, which generates a transcript encoding a protein lacking
the functionally crucial Ca
2+-dependent lipid binding domain (C2
domain) [19]. NEDD4L and its paralog NEDD4 lacking the C2
domain, down-regulate ENaC more potently than NEDD4L with
an intact C2 domain [16,20–22] suggesting that carriers of the
NEDD4L rs4149601 G-allele have higher ENaC expression and
higher renal sodium reabsorption through ENaC than carriers of
the A-allele. In consequence, we found that subjects with the GG
genotype of rs4149601, as compared with carriers of the AA-
genotype, had higher diastolic blood pressure [18]. Furthermore,
subjects with the GG-genotype simultaneously carrying at least
one copy of the C-allele of the NEDD4L rs2288774 TRC
polymorphism in intron 6 had significantly higher systolic and
diastolic blood pressure compared to non-carriers of this genotype
combination, suggesting that carriers have increased tubular
sodium reabsorption due to the decreased capacity of NEDD4L
to down regulate ENaC. As expected in a highly complex and
polygenic trait as blood pressure, the effect of the genotype com-
bination on systolic and diastolic blood pressure was moderate,
approximately 2/1 mmHg [18].
Given our previous findings and the well-described interaction
between NEDD4L and ENaC, our aim was to elucidate whether
the NEDD4L rs4149601 GG-genotype in combination with at
least one C-allele of the NEDD4L rs2288774 polymorphism
would be associated with increased salt sensitivity, reduced levels
of P-renin and increased levels of Nt-proANP.
METHODS
The protocol of the study was approved by the ethics committee of
Lunds University, and all study participants gave written informed
consent. The procedures were in accordance with institutional
guidelines.
Subjects
Forty-six subjects with no history of hypertension, diabetes or
kidney diseases were recruited through newspaper advertisements.
Of these, 7 did not complete the study because of infections with
fever (n=2) or refusal to take the study capsules regularly (n=5).
Thus, 39 healthy subjects (53611 years of age, BMI 26.363.1 kg/
m
2, number of men/women 20/19) completed the study. Other
phenotype characteristics are presented in Table 1.
Design
All the subjects were first examined at baseline, i.e. with the
subjects on their regular diets before the standardization of salt
intake started. During a period of eight weeks the subjects were
given all their meals and drinks from a metabolic ward. Energy
intake was adjusted according to body weight and gender (2000–
2600 kcal/day). Apart from the provided meals and drinks,
subjects were prohibited to ingest anything else apart from tap
water. The diet during the eight weeks of study contained
50 mmol of salt (NaCl) daily. On top of this, the study participants
were given either 100 mmol of salt in capsules (totally 150 mmol
of salt daily) for four weeks and corresponding number of placebo
capsules (totally 50 mmol of salt daily) for four weeks in a random
order double blind crossover design [11].
Ambulatory blood pressure (ABP) and 24-hour urinary
excretion of sodium were measured at baseline, after the four
weeks on the high salt intake (150 mmol daily) and after the four
weeks of low salt intake (50 mmol daily). ABP was measured using
an ABPM 90207 device (Spacelabs Medical Inc, Redmond, WA,
USA), which was applied on their left arm using appropriate cuff
sizes according to arm circumference. During the daytime period
(6 am–10 pm) blood pressure was recorded every 20 min and
during the nighttime period (10 pm–06 am) every 60 min.
Subjects were advised to relax the arm and keep it along the
body during blood pressure measurements. Urine was collected
during the same 24-hour as the ABP measurements.
Salt sensitivity was defined as the difference between 24-hour
systolic ABP after the four weeks on high salt intake and 24-hour
systolic ABP after the 4 weeks on low salt intake. In addition, the
salt induced change in diastolic ABP (diastolic salt sensitivity) was
recorded and systolic and diastolic salt sensitivity were further
divided into the daytime and nighttime periods. P-renin and Nt-
proANP were measured at baseline in the upright position without
prior rest using RIA diagnostic kits as described previously [9,10].
Urine and serum concentrations of sodium, potassium and
creatinine were measured by standard biochemical methods at
baseline, after the high- and low salt intake periods.
Genotyping
DNA was extracted from venous whole blood by standard
methods [23]. Two variants in the NEDD4L gene (rs4149601,
GRA in exon 1 and rs2288774, TRC, in intron 6) were
genotyped using PCR. The polymorphisms were analysed using
forward primer 59-GCTTTCCTTTAATGCACTAAACCTTT-
AATATTGT-39 and reverse primer 59-GGTAAGACTTTGCT-
TGGTGGGG-39 (rs4149601) and forward primer 59-ACAGTC-
TCATGTTTGATGCTTCGT-39 and reverse primer 59-AGA-
AGGCTGAAATGAAGCACGT-39 (rs2288774) synthesized by
Applied Biosystems (Applied Biosystems, Foster City, California,
USA). TaqMan MGB probes were custom synthesized by Applied
Biosystems: (rs4149601, G) FAM-ATTTGAGCAGGTAACAC,
NEDD4L and Salt Sensitivity
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(rs2288774, T) FAM-CACTCTGAAAATACACTGACT,
(rs2288774, C) VIC-CACTCTGAAAATACGCTGACT, accord-
ing to standard recommendations for the ABI Prism 7900HT
analysis system (Applied Biosystems, Foster City, California, USA).
Genotypes were determined by end-point fluorescent measure-
ments [24].
Statistics
All data in the study was analyzed with SPSS statistical software
(version 11.5, SPSS Inc. Chicago, Illinois, USA). Data is presented
as mean6standard deviation (SD) for normally distributed vari-
ables and as medians and interquartile ranges (IQR) for variables
that were not normally distributed. Significance of group-wise and
pair-wise differences in continuous variables was tested with t-test/
paired t-test or Mann-Whitney/Wilcoxons paired rank test
depending on whether data was normally distributed or not.
P,0.05 was considered statistically significant.
RESULTS
The rs4149601 (exon 1) and rs2288774 (intron 6) polymorphisms
were tested separately and in combination for association to salt
sensitivity indices and to baseline levels of Nt-proANP and P-
renin.
Carriers of the rs4149601 GG-genotype had significantly lower
P-renin than carriers of the rs4149601 GA or AA genotypes
whereas no other phenotype differed significantly by genotype
(Table 2). There was no association between any of the phenotypes
and the rs2288774 polymorphism (Table 2).
Carriers of the rs4149601 GG-genotype together with the
rs2288774 CC-or CT-genotype, as compared to non-carriers of
this combination, displayed significantly lower P-renin and
borderline significance for systolic salt sensitivity (P=0.06–0.08)
whereas there was no significance in diastolic salt sensitivity and
Nt-proANP (Table 3).
Carriers of the rs4149601 GG-genotype together with the
rs2288774 CC-genotype had significantly higher 24-hour, daytime
and nighttime systolic salt sensitivity, lower P-renin and higher Nt-
proANP when compared with non-carriers (Fig 1 and Table 3),
whereas the differences in indices of diastolic salt sensitivity were
not statistically significant.
DISCUSSION
The key finding of this study is that the carriers of the rs4149601
GG-genotype together with rs2288774 CC-genotype have en-
hanced systolic salt sensitivity, lower P-renin and higher Nt-
proANP compared with subjects who do not carry this genotype
combination of the NEDD4L gene.
NEDD4L and its paralog NEDD4 lacking the functionally
crucial C2-domain down-regulate ENaC more potently than the
protein variants with intact C2-domain [16,20–22]. As the
rs4149601 A-allele alters a splice site leading to preferential
deletion of the C2 domain [19], subjects carrying the G-allele
would be expected to have a less efficient NEDD4L induced down
regulation of ENaC and thus increased renal sodium reabsorption.
Interestingly, carriers of the rs4149601 GG-genotype had signifi-
cantly lower P-renin but did not differ regarding salt sensitivity
(Table 2), indicating reduced activity of the renin-angiotensin-
aldosterone system (RAAS) as a response to a slight increase in
renal sodium reabsorption in order to counterbalance the effect of
the GG-genotype on salt sensitivity. Carrier ship of the rs2288774
CC-genotype seemed to amplify the effect of the rs4149601,
thereby unmasking clinically detectable salt sensitivity. In contrast
to the rs4149601, the functional consequence of the rs2288774 at
the molecular level is unknown. The NEDD4L gene is highly
polymorphic suggesting that the rs2288774 polymorphism in
intron 6 could be non-functional but be in linkage disequilibrium
with another functional NEDD4L variant. Interestingly, intronic
SNP:s in the transcription factor 7-like 2 (TCF7L2) gene have
been strongly associated with another complex phenotype, that of
Table 1.
..................................................................................................................................................
Baseline High salt Low salt P* (high-vs. low-salt)
24-hour SBP (mmHg) 139613.3 136612.7 131611.1 ,0.0001
24-hour DBP (mmHg) 86.367.4 85.067.0 82.366.6 0.004
24-hour HR (bpm) 72.369.0 67.768.4 69.167.9 0.08
Daytime SBP (mmHg) 144613.2 141612.8 135611.7 ,0.0001
Daytime DBP (mmHg) 90.667.8 89.267.3 86.966.9 0.02
Daytime HR (bpm) 76.169.7 67.768.4 73.869.1 0.04
Night-time SBP (mmHg) 129614.4 128613.6 121611.5 ,0.0001
Night-time DBP (mmHg) 77.567.9 76.467.6 73.067.9 0.002
Night-time HR (bpm) 64.469.0 58.468.2 59.566.9 0.17
Body weight (kg) 79.5611.2 77.4610.7 77.3610.6 0.43
Urine-Na
+ (mmol/24h) 165667.4 140639.5 50.7617.3 ,0.0001
Urine-K
+ (mmol/24h) 75.0622.9 50.8611.3 50.9614.1 0.94
Urine-Crea (mmol/24h) 13.163.3 12.362.7 12.263.0 0.65
Serum-Na
+ (mmol/L) 14061.8 14161.5 13961.7 ,0.0001
Serum-K
+ (mmol/L) 3.760.26 3.660.25 3.760.30 0.21
Serum-Crea (mmol/L) 78.4612.8 80.4612.8 84.1612.6 0.001
Plasma renin (mU/L) 15.369.4 17.4611.2 32.4618.4 ,0.0001
Refer to individual change of variable on high- as compared with on low-salt (i.e. variable D-value). SBP, systolic blood pressure; DBP, diastolic blood pressure; Crea,
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ethnicities [25]. Thus, another possibility is that rs2288774 is
functional, despite being intronic. Such functional mechanisms
may involve interference with intronic transcription factor binding
sites, leading to altered NEDD4L expression, or introduction of
a cryptic splice site. Importantly, in a recent study on genetic
NEDD4L variance and blood pressure in subjects without
antihypertensive treatment, we found that the rs4149601 poly-
morphism seems to interact with another NEDD4L polymor-
phism, rs2288774 [18]. In that study carriers of the rs4149601
GG-genotype together with rs2288774 CT or CC-genotypes had
approximately 2/1 mmHg higher office blood pressure compared
to non-carriers [18]. Carriers of the same genotype combination in
the present study tended to have higher systolic salt sensitivity and
had significantly lower P-renin (Table 3). On the other hand,
carriers of the rs4149601 GG-genotype together with rs2288774
CC-genotype, who had the greatest systolic salt sensitivity in the
present study (Table 3), did not have significantly higher blood
pressure in the previous population study [18]. Although related, it
is important to stress that blood pressure and salt sensitivity are
different phenotypes. The relatively greater suppression of baseline
P-renin in carriers of the rs4149601 GG-genotype together with
rs2288774 CC-genotype compared to that seen in carriers of
rs4149601 GG-genotype together with rs2288774 CT or CC-
genotypes (Table 3) may level out the effect on blood pressure
through RAAS-dependent mechanisms other than those directly
affecting renal sodium reabsorption. Despite the substantially
smaller material used in the present study, as compared with the
previous population study on blood pressure, there were several
reasons to believe that we would have power enough to detect an
effect of the NEDD4L polymorphisms on salt sensitivity. Most
importantly, salt sensitivity is a much less complex phenotype than
blood pressure. Blood pressure is influenced by numerous
environmental factors such as stress, physical activity, caloric
intake and level of salt intake. Although salt sensitivity may also be
affected by a number of environmental factors, the standardized
phenotype of salt sensitivity used in the present study is primarily
influenced by the shift of salt intake from 150 mmol to 50 mmol
daily and the individual inherited and acquired capacity of
handling changes in salt intake. As fewer environmental factors are
implicated in salt sensitivity than in blood pressure, it can be
speculated that fewer genes conferring gene-environment interac-
tions are involved in salt sensitivity. In addition, whereas heritability
of blood pressure is usually around 30–40%, that of systolic salt
sensitivity has been reported to be as high as 74% [5], suggesting
a substantially greater genetic component of systolic salt sensitivity
than for blood pressure. Finally, in our previous study on blood
pressure, the phenotype used was office blood pressure, whereas in
the present study of salt sensitivity the more accurate blood pressure
phenotype of ABP was used to define blood pressure after the two
different levels of salt intake. Taken together, the effect of genetic
variance of proteins involved in the process of renal sodium
reabsorption, such as NEDD4L, is likely to be much greater on the
phenotype of salt sensitivity than on population blood pressure.
P-renin and Nt-proANP measured under non-standardized
conditions of salt intake have earlier been shown to predict salt
sensitivity [9,19]. A likely explanation for this is that salt sensitivity is
a state of sodium hyper-reabsorption at the level of the renal tubules,
leading to suppression of RAAS due to increased flow of sodium
through the juxtaglomerular apparatus of the kidney and to
increased atrial secretion of Nt-proANP as a consequence of atrial
wall distension. This potential mechanism as the cause of enhanced
salt sensitivity is supported by the pathophysiology of monogenic
forms of human hypertension, such as Liddles syndrome [14], in
Table 2. Salt-induced changes in blood pressure and baseline P-renin and Nt-proANP in different genotype carriers.
..................................................................................................................................................
rs4149601 genotype variants
GG (n=16) GA (n=20) AA (n=3) P-value; GG vs GA or AA
D24SBP(mmHg) 6.5(3.0–13) 6.5(0.0–10) 2.0(28.0–15) 0.315
D24DBP(mmHg) 1.5(21.0–9.75) 3.5(20.5–5.75) 21.0(25.0–8.0) 0.703
DDSBP(mmHg) 6.5(2.0–14.5) 6.0(22.0–9.0) 5.0(26.0–7.0) 0.343
DDDBP(mmHg) 2.0(23.0–9.75) 2.0(21.0–4.75) 1.0(25.0–3.0) 0.921
DNSBP(mmHg) 11.5(2.25–15) 6.0(0.25–9.0) 23.0(215–30) 0.107
DNDBP(mmHg) 4.5(1.25–9.5) 4.0(22.75–7.0) 24.0(28.0–16.0) 0.196
P-renin(mU/L) 10.5(6.5–15.8) 18.0(10.0–28.0) 9.0(2.0–25.0) 0.045
Nt-proANP(pmol/L) 510(419–803) 510(422–646) 620(440–786) 0.641
rs2288774 genotype variants
CC (n=12) CT (n=14) TT (n=13) P-value; CC vs CT or TT
D24SBP(mmHg) 7.5(3.0–16.5) 4.0(21.25–7.75) 7.0(2.5–12) 0.168
D24DBP(mmHg) 4.5(20.5–8.25) 1.0(22.0–4.0) 3.0(21.0–6.5) 0.221
DDSBP(mmHg) 7.5(2.75–19) 3.5(22.0–7.0) 7.0(0.5–11.0) 0.178
DDDBP(mmHg) 3.0(0.25–9.75) 20.5(21.5–4.0) 3.0(22.0–5.5) 0.188
DNSBP(mmHg) 9.0(0.25–15) 4.5(21.0–8.75) 9.0(3.5–12.5) 0.443
DNDBP(mmHg) 5.5(22.75–8.0) 3.5(22.25–7.0) 5.0(2.0–7.5) 0.845
P-renin(mU/L) 10.5(6.5–19.5) 14.0(9.0–21.5) 14.5(6.75–28.75) 0.185
Nt-proANP(pmol/L) 659(438–844) 559(359–732) 489(436–599) 0.150
Blood pressure change in low versus (vs) high salt intake; D24SBP, delta 24-hour systolic blood pressure; D24DBP, delta 24-hour diastolic blood pressure; DDSBP, delta
daytime systolic blood pressure; DDDBP, delta daytime diastolic blood pressure; DNSBP, delta night-time systolic blood pressure; DNDBP; delta night-time diastolic
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PLoS ONE | www.plosone.org 4 May 2007 | Issue 5 | e432which over-expression of ENaC in the distal nephron leads to hyper-
reabsorption of sodium, volume expansion, suppression of RAAS
and extremely salt sensitive hypertension. Thus, the associations
betweentheNEDD4Lrs4149601andrs2288774polymorphismson
the one hand and P-renin and Nt-proANP on the other, are likely to
be secondary to genetically mediated enhancement of tubular
sodium reabsorption rather than being a direct effect of the genetic
variants on renin and Nt-proANP secretion.
Our associations were generally stronger for systolic than for
diastolic salt sensitivity (Tables 2 and 3). This is probably explained
by the fact that the heritability of systolic salt sensitivity is
substantially higher than for diastolic salt sensitivity [5] giving us
a greater power to detect genetic factors influencing systolic salt
sensitivity.
In summary, we show that carriers of the rs4149601 GG-
genotype together with rs2288774 CC-genotype of the NEDD4L
gene have enhanced systolic salt sensitivity, lower P-renin and
higher Nt-proANP. Our data suggests that carriers of this
genotype combination have increased renal sodium reabsorption
through reduced NEDD4L induced down-regulation of ENaC. As
salt sensitivity differs a lot between individuals, genotyping of these
genetic NEDD4L markers may be a clinically useful tool in
identifying those individuals who would gain the greatest blood
pressure lowering benefit from reduced dietary salt intake.
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Table 3. Salt-induced changes in blood pressure, and baseline
P-renin and Nt-proANP in different genotype carriers.
......................................................................
rs4149601 GG+rs2288774 CC/CT genotype variants vs
non-carriers
GG+CC/CT (n=11) Non-carriers (n=28) P-value
D24SBP(mmHg) 8.0(6.0–18) 5.0(0.0–10) 0.067
D24DBP(mmHg) 2.0(21.0–11) 2.0(21.0–5.75) 0.158
DDSBP(mmHg) 8.0(4.0–19) 5.0(22.0–8.75) 0.058
DDDBP(mmHg) 4.0(23.0–11) 1.5(21.0–3.75) 0.140
DNSBP(mmHg) 14.0(2.0–15) 5.5(0.0–9.0) 0.083
DNDBP(mmHg) 8.0(1.0–10) 4.0(22.75–7.0) 0.124
P-renin(mU/L) 9.0(6.0–16) 15.0(9.0–28.0) 0.030
Nt-proANP(pmol/L) 754(426–880) 493(422–622) 0.109
rs4149601 GG+rs2288774 CC genotype vs non-carriers
GG+CC (n=5) Non-carriers (n=34) P-value
D24SBP(mmHg) 18(7.5–20) 6.0(0.0–10) 0.007
D24DBP(mmHg) 9.0(0.5–13.5) 1.5(21.25–6.0) 0.081
DDSBP(mmHg) 19(5.0–21.5) 5.0(22.0–9.0) 0.024
DDDBP(mmHg) 9.0(0.0–13.5) 1.5(21.0–4.0) 0.117
DNSBP(mmHg) 15.0(12.5–20) 5.0(20.25–9.5) 0.001
DNDBP(mmHg) 8.0(4.5–11) 4.0(22.0–7.0) 0.089
P-renin(mU/L) 6.0(2.0–9.5) 15.0(9.0–24.0) 0.005
Nt-proANP(pmol/L) 806(590–1186) 493(417–655) 0.031
Blood pressure change in low versus (vs) high salt intake; D24SBP, delta 24-hour
systolic blood pressure; D24DBP, delta 24-hour diastolic blood pressure; DDSBP,
delta daytime systolic blood pressure; DDDBP, delta daytime diastolic blood
pressure; DNSBP, delta night-time systolic blood pressure; DNDBP; delta night-
time diastolic blood pressure. P-value,0.05 is considered statistically
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